Ilaria Craparotta - Concepedia

Author

Ilaria Craparotta

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

Craparotta, Ilaria, I Craparotta, I. Craparotta, Ilaria Craparotta, Jenny van Dongen

Publications

Citations

H-Index

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research Istituti di Ricovero e Cura a Carattere Scientifico University of Padua Humanitas University University of Milano-Bicocca

About

Ilaria Craparotta is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	423
2	Cell Biology	5	5	289
3	Immunology	3	3	239
4	Social Sciences	2	2	110
5	Neurology	2	2	110

Ilaria Craparotta

Publications

979

Citations

H-Index

Page 1

	Year	Citations
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models Cristina Belgiovine, Ezia Bello, Manuela Liguori, British Journal of Cancer	2017	149
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 Manuela Liguori, Elisabeth Digifico, Alessandro Vacchini, Cellular and Molecular Immunology Cancer ResearchSoluble Glycoprotein NmbMedicineImmunologyTumor Suppressor	2020	125
n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis Federica Frigerio, Giulia Pasqualini, Ilaria Craparotta, Brain Synaptic TransmissionImmunologyImmune RegulationSynaptic SignalingSocial Sciences	2018	92
Bone marrow fibroblasts overexpress miR‐27b and miR‐214 in step with multiple myeloma progression, dependent on tumour cell‐derived exosomes Maria Antonia Frassanito, Vanessa Desantis, Lucia Di Marzo, The Journal of Pathology	2018	91
lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study Paolo Martini, Lara Paracchini, Giulia Caratti, Clinical Cancer Research	2016	66
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies Marco Petrillo, Gian Franco Zannoni, Luca Beltrame, Annals of Oncology Neoadjuvant ChemotherapyMedicineMatched Tumor BiopsiesDrug ResponsePathology	2016	61
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study Luca Beltrame, Mariacristina Di Marino, Robert Fruscio, Annals of Oncology Retrospective StudyOncologySomatic VariantTumor HeterogeneityMedicine	2015	55
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells Monica Mancini, Marzia Bruna Gariboldi, Elisa Taìana, British Journal of Cancer	2014	44
The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil Marzia Bruna Gariboldi, Elisa Taìana, Maria Chiara Bonzi, Cancer Letters Cancer ResearchOncologyGastrointestinal OncologyMedicineHif-1 Transcriptional Activity	2015	29
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies Lara Paracchini, Laura Mannarino, Ilaria Craparotta, Oncotarget	2016	29

Page 1